Raltitrexed enhanced antitumor effect of anlotinib in human esophageal squamous carcinoma cells on proliferation, invasiveness, and apoptosis Hongchao Zhen et al, 2023, BMC Cancer CrossRef
Raltitrexed increases radiation sensitivity of esophageal squamous carcinoma cells Wen-Xiu Ding et al, 2019, Cancer Cell International CrossRef
Conserved molecular mechanisms underlying the effects of small molecule xenobiotic chemotherapeutics on cells HEMANT SARIN, 2016, Molecular and Clinical Oncology CrossRef
Synthesis, characterization and ROS-mediated antitumor effects of palladium(II) complexes of curcuminoids Yanci Li et al, 2018, European Journal of Medicinal Chemistry CrossRef
(3R)‑5,6,7‑trihydroxy‑3‑isopropyl‑3‑methylisochroman‑1‑one inhibited osteosarcoma growth by inducing apoptosis Ming‑Zhu Song et al, 2019, Experimental and Therapeutic Medicine CrossRef
Thymidylate synthase is essential for efficient HIV-1 replication in macrophages Vincent Desrosiers et al, 2021, Virology CrossRef
Raltitrexed Enhances the Antitumor Effect of Apatinib in Human Esophageal Squamous Carcinoma Cells via Akt and Erk Pathways
Hongchao Zhen et al, 2020, OncoTargets and Therapy CrossRef
Clinical Outcomes of Drug-Eluting Bead Transarterial Chemoembolization Loaded with Raltitrexed for the Treatment of Unresectable or Recurrent Hepatocellular Carcinoma Yonghua Bi et al, 2022, Canadian Journal of Gastroenterology and Hepatology CrossRef
A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells Gaetano Marverti et al, 2020, International Journal of Molecular Sciences CrossRef
Effect of evodiamine on the proliferation and apoptosis of A549 human lung cancer cells Li Lin et al, 2016, Molecular Medicine Reports CrossRef
Repurposing of Raltitrexed as an Effective G9a/EHMT2 Inhibitor and Promising Anti-Alzheimer’s Agent Abhisek Jana et al, 2023, ACS Medicinal Chemistry Letters CrossRef
Raltitrexed induces apoptosis through activating ROS-mediated ER stress by impeding HSPA8 expression in prostate cancer cells Yan Tao et al, 2024, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
FDA-approved pyrimidine-fused bicyclic heterocycles for cancer therapy: Synthesis and clinical application Shuai Wang et al, 2021, European Journal of Medicinal Chemistry CrossRef
Raltitrexed Inhibits HepG2 Cell Proliferation via G0/G1 Cell Cycle Arrest Hongwei Zhao et al, 2016, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
FDA approved six-membered ring fused pyrimidine-based derivatives Sahil Arora et al, 2023, Fused Pyrimidine-Based Drug Discovery CrossRef
15‑hydroxy‑6α,12‑epoxy‑7β,10αH,11βH‑spiroax‑4‑ene‑12‑one exerts anti‑tumor effects against osteosarcoma through apoptosis induction Tian‑Zhi An et al, 2020, Experimental and Therapeutic Medicine CrossRef
Preliminary outcomes of DEB-TACE loaded with raltitrexed in the treatment of unresectable or recurrent hepatocellular carcinoma Yonghua Bi et al, 2023, Cancer Imaging CrossRef
Raltitrexed regulates proliferation and apoptosis of HGC-27 cells by upregulating RSK4 Cong Hu et al, 2022, BMC Pharmacology and Toxicology CrossRef
Raltitrexed plus oxaliplatin-based transarterial chemoembolization in patients with unresectable hepatocellular carcinoma Chang Zhao et al, 2016, Anti-Cancer Drugs CrossRef
Cytoprotective Effect of Morchella esculenta Protein Hydrolysate and Its Derivative Against H2O2-Induced Oxidative Stress Qiang Zhang et al, 2019, Polish Journal of Food and Nutrition Sciences CrossRef
Hyperthermic intraperitoneal chemotherapy with recombinant mutant human TNF-α and raltitrexed in mice with colorectal-peritoneal carcinomatosis Qianyi Gong et al, 2020, Experimental Biology and Medicine CrossRef
Anticancer Biological Profile of Some Heterocylic Moieties-Thiadiazole, Benzimidazole, Quinazoline, and Pyrimidine Parin Salim Sidat et al, 2022, Pharmacophore CrossRef